Reducing Particulate Matter-Associated Cardiovascular Health Effects for Seniors
减少颗粒物对老年人心血管健康的影响
基本信息
- 批准号:10427306
- 负责人:
- 金额:$ 52.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-06-06 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:AccountingAcuteAddressAdrenal GlandsAdultAirAir PollutionAirborne Particulate MatterAmericanAsiaBloodBlood PressureBlood VesselsCardiovascular systemCessation of lifeChronicClinicalClinical TrialsCross-Over StudiesDataDiastolic blood pressureDouble-Blind MethodEffectivenessElderlyEnvironmentEventExposure toFaceFiltrationGlucocorticoidsGrantGuidelinesHairHealthHeart failureHospitalizationHot SpotHousingHydrocortisoneHypertensionIncidenceInsulin ResistanceInterventionIntervention StudiesLocationLong-Term EffectsLow incomeMediator of activation proteinMineralocorticoidsMorbidity - disease rateMyocardial InfarctionNIH Program AnnouncementsOutcomeParticulateParticulate MatterPathway interactionsPopulationPopulation HeterogeneityPopulations at RiskPrevention strategyPublic HealthRandomizedResidential FacilitiesResolutionRestRiskRisk FactorsSalivarySteroidsStrokeTimeTranslatingVulnerable PopulationsWorld Health Organizationair filtrationblood pressure elevationcardiometabolismcardiovascular healthcardiovascular risk factorclinically relevantcostevidence basefine particleshemodynamicshypothalamic-pituitary-adrenal axisimprovedindexingindoor airindoor particulate matterinsightinsulin sensitivitymortalitynovelnovel strategiespollutantportabilityprimary endpointprimary outcomeresidencescale upsecondary outcomesuccesstrend
项目摘要
Project Summary/Abstract
Fine particulate matter <2.5 µm (PM2.5) air pollution is the fifth leading risk factor for mortality worldwide.
Over 88 thousand deaths per year are attributable to PM2.5 in the US alone, with the largest portion from
cardiovascular (CV) causes (myocardial infarctions, strokes, heart failure). Despite improvements across the
US, PM2.5 remains above World Health Organization Air Quality Guidelines (<10 µg/m3) in numerous hot-spots
(e.g., near roadways). Therefore, it is critical to develop feasible and effective personal strategies to protect
“vulnerable” (urban/near-roadway) and “susceptible” (elderly) populations at risk from the harmful effects of
PM2.5.
Emerging trials have shown that portable indoor air filtration units (AFUs) with high-efficiency particulate
arrestance filters can reduce PM2.5 exposures by 30-50% and improve CV health endpoints (e.g., BP, vascular
function). Our recent clinical trial results confirm that even low PM2.5 levels pose significant risks to CV health
and that portable indoor air filtration units (AFUs) represent a promising preventative strategy. However, no
study has addressed whether exposure reductions and health improvements can be sustained over more
clinically relevant periods of intervention (i.e., several weeks) which are required to plausibly yield decreases in
actual CV events. In addition, the efficacy of the novel practical (i.e., less expensive and more feasible in real-
world settings) approach of using a single AFU only in the bedroom to focus on reducing nocturnal PM2.5
exposure is currently unknown.
This proposal seeks to conduct a randomized double-blind 3-way crossover intervention study (AFUs in 2
rooms vs. bedroom AFU use alone vs. sham filtration) in 50 adults living in a low-income senior residence
impacted by roadway pollutants. Specific Aims are: (1) determine if long-term, 2-room AFU usage provides
sustained reductions in PM2.5 exposure and persistent improvements in cardiometabolic outcomes; (2)
determine if nocturnal PM2.5 exposure reduction alone improves cardiometabolic outcomes; and (3)
demonstrate the key role of adrenal activation as a novel mechanism explaining PM2.5-induced cardiometabolic
changes. Our proposal will help validate the benefits of novel strategies to employ AFUs in an elderly
vulnerable population. Positive results would represent a key step in forming the evidence base required to
promote more wide-scale AFU use; in the long term, given their low cost and burden, AFU use could be up-
scaled to help protect diverse populations.
项目概要/摘要
<2.5 µm 细颗粒物 (PM2.5) 空气污染是全球第五大死亡风险因素。
仅在美国,每年就有超过 8.8 万人死于 PM2.5,其中最大部分来自 PM2.5
心血管(CV)原因(心肌梗塞、中风、心力衰竭)尽管有所改善。
美国许多热点地区的 PM2.5 仍高于世界卫生组织空气质量准则(<10 µg/m3)
(例如,靠近道路),制定可行且有效的个人保护策略至关重要。
“弱势群体”(城市/近道路)和“易感群体”(老年人)面临以下有害影响的风险
PM2.5。
新兴试验表明,具有高效颗粒物的便携式室内空气过滤装置 (AFU)
阻滞过滤器可将 PM2.5 暴露量减少 30-50%,并改善 CV 健康终点(例如血压、血管
我们最近的临床试验结果证实,即使 PM2.5 水平较低也会对心血管健康构成重大风险。
便携式室内空气过滤装置(AFU)代表了一种有前途的预防策略。
研究探讨了暴露减少和健康改善是否可以持续更长时间
临床相关的干预期(即几周)需要合理地减少
此外,新颖实用的功效(即在现实中更便宜且更可行)
世界设置)仅在卧室使用单个 AFU 的方法,专注于减少夜间 PM2.5
目前曝光情况未知。
该提案旨在开展一项随机双盲三向交叉干预研究(AFUs in 2
房间与卧室(单独使用 AFU 与假过滤)对居住在低收入高级住宅的 50 名成年人进行
受道路污染物的影响 具体目标是: (1) 确定 2 室 AFU 的长期使用是否能够提供
PM2.5 暴露持续减少并持续改善心脏代谢结果 (2)
确定仅减少夜间 PM2.5 暴露是否可以改善心脏代谢结果;以及 (3)
证明肾上腺激活作为解释 PM2.5 诱导的心脏代谢的新机制的关键作用
我们的建议将有助于验证在老年人中使用 AFU 的新策略的好处。
弱势群体的积极结果将代表着形成所需证据基础的关键一步。
促进更广泛的 AFU 使用;从长远来看,鉴于 AFU 的成本和负担较低,AFU 的使用可能会增加
规模化以帮助保护不同人群。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Cardiometabolic Risk Factor Control During Times of Crises and Beyond.
危机时期及之后的心脏代谢风险因素控制。
- DOI:
- 发表时间:2020
- 期刊:
- 影响因子:0
- 作者:Brook, Robert D;Levy, Phillip;Rajagopalan, Sanjay
- 通讯作者:Rajagopalan, Sanjay
Reduction of personal PM2.5 exposure via indoor air filtration systems in Detroit: an intervention study.
底特律通过室内空气过滤系统减少个人 PM2.5 暴露:一项干预研究。
- DOI:
- 发表时间:2019
- 期刊:
- 影响因子:0
- 作者:Maestas, Melissa M;Brook, Robert D;Ziemba, Rosemary A;Li, Fengyao;Crane, Ryan C;Klaver, Zachary M;Bard, Robert L;Spino, Catherine A;Adar, Sara D;Morishita, Masako
- 通讯作者:Morishita, Masako
Limitations in the Methodology Assessing Blood Pressure and the Need for Strict Exclusion Criteria-Reply.
评估血压方法的局限性和严格排除标准的必要性-答复。
- DOI:
- 发表时间:2019
- 期刊:
- 影响因子:39
- 作者:Brook, Robert D;Morishita, Masako
- 通讯作者:Morishita, Masako
Reduction of Outdoor and Indoor PM2.5 Source Contributions via Portable Air Filtration Systems in a Senior Residential Facility in Detroit, Michigan.
在密歇根州底特律的高级住宅设施中,通过便携式空气过滤系统减少室外和室内 PM2.5 来源。
- DOI:
- 发表时间:2023-12-14
- 期刊:
- 影响因子:4.6
- 作者:Klaver, Zachary M;Crane, Ryan C;Ziemba, Rosemary A;Bard, Robert L;Adar, Sara D;Brook, Robert D;Morishita, Masako
- 通讯作者:Morishita, Masako
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Robert Daniel Brook其他文献
Robert Daniel Brook的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Robert Daniel Brook', 18)}}的其他基金
Reducing Particulate Matter-Associated Cardiovascular Health Effects for Seniors
减少颗粒物对老年人心血管健康的影响
- 批准号:
10011861 - 财政年份:2014
- 资助金额:
$ 52.75万 - 项目类别:
Reducing Particulate Matter-Associated Cardiovascular Health Effects for Seniors
减少颗粒物对老年人心血管健康的影响
- 批准号:
10207776 - 财政年份:2014
- 资助金额:
$ 52.75万 - 项目类别:
ASPIRE: Air Pollution: Strategies for Personalized Intervention to Reduce Exposure
ASPIRE:空气污染:减少接触的个性化干预策略
- 批准号:
9754146 - 财政年份:2011
- 资助金额:
$ 52.75万 - 项目类别:
COUNTERACT Supplement--ASPIRE: Air Pollution: Strategies for Personalized Intervention to Reduce Exposure
COUNTERACT 补充--ASPIRE:空气污染:减少接触的个性化干预策略
- 批准号:
10218398 - 财政年份:2011
- 资助金额:
$ 52.75万 - 项目类别:
CARDIOVASCULAR LINKAGE BETWEEN ENDOTHELIAL FUNCTION & AIR POLLUTION
内皮功能之间的心血管联系
- 批准号:
7603730 - 财政年份:2007
- 资助金额:
$ 52.75万 - 项目类别:
VASCULAR TISSUE ANGIOTENSINII & ENDOTHELIAL DYSFUNCTION IN UNCOMPLICATED OBESITY
血管组织血管紧张素II
- 批准号:
7376511 - 财政年份:2006
- 资助金额:
$ 52.75万 - 项目类别:
CARDIOVASCULAR LINKAGE BETWEEN ENDOTHELIAL FUNCTION & AIR POLLUTION
内皮功能之间的心血管联系
- 批准号:
7376546 - 财政年份:2006
- 资助金额:
$ 52.75万 - 项目类别:
相似国自然基金
巨噬细胞Nogo-B通过FABP4/IL-18/IL-18R调控急性肝衰竭的分子机制研究
- 批准号:82304503
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
α7nAChR激动剂通过PGC-1α和HO-1调控肾小管上皮细胞线粒体的质和量进而改善脓毒症急性肾损伤的机制研究
- 批准号:82372172
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
基于解郁散热“把好气分关”探讨代谢-炎症“开关”A2BR在急性胰腺炎既病防变中的作用与机制
- 批准号:82374256
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
RacGAP1介导细胞核-线粒体对话在急性肾损伤中促进肾小管上皮细胞能量平衡的作用机制研究
- 批准号:82300771
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
开窍寒温配伍调控应激颗粒铁离子富集水平抗急性缺血性卒中铁死亡损伤的机制研究
- 批准号:82374209
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Climate Change Effects on Pregnancy via a Traditional Food
气候变化通过传统食物对怀孕的影响
- 批准号:
10822202 - 财政年份:2024
- 资助金额:
$ 52.75万 - 项目类别:
3/4-American Consortium of Early Liver Transplantation-Prospective Alcohol-associated liver disease Cohort Evaluation (ACCELERATE-PACE)
3/4-美国早期肝移植联盟-前瞻性酒精相关性肝病队列评估(ACCELERATE-PACE)
- 批准号:
10711001 - 财政年份:2023
- 资助金额:
$ 52.75万 - 项目类别:
Achieving Health Equity During the COVID-19 Pandemic: Lessons Learned from Nurses and High Performing Hospitals
在 COVID-19 大流行期间实现健康公平:从护士和高绩效医院汲取的经验教训
- 批准号:
10655888 - 财政年份:2023
- 资助金额:
$ 52.75万 - 项目类别:
Development of Patient-Tailored Adaptive Treatment Strategies for Acute Severe Ulcerative Colitis
制定针对急性重症溃疡性结肠炎的患者定制适应性治疗策略
- 批准号:
10569397 - 财政年份:2023
- 资助金额:
$ 52.75万 - 项目类别: